Research
Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital
Published

Serum YKL-40 in Risk Assessment for Colorectal Cancer: A Prospective Study of 4,496 Subjects at Risk of Colorectal Cancer

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Breast cancer risk factors and survival by tumor subtype: Pooled analyses from the breast cancer association consortium

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Childhood overweight, tallness and growth increase risks of ovarian cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Long-term Exposure to Fine Particulate Matter and Breast Cancer Incidence in the Danish Nurse Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Vitamin d and cancer incidence-response

    Research output: Contribution to journalComment/debateResearchpeer-review

  5. Vitamin d and cancer incidence-response to grant

    Research output: Contribution to journalComment/debateResearchpeer-review

  1. Corrigendum to "Large Incisional Hernias Increase in Size" [Journal of Surgical Research 2019; 244: 160-165.]

    Research output: Contribution to journalComment/debateResearchpeer-review

  2. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Impact of the COVID-19 pandemic on the management of colorectal cancer in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Reporting guideline for interventional trials of primary and incisional ventral hernia repair

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Julia S Johansen
  • Ib J Christensen
  • Lars N Jørgensen
  • Jesper Olsen
  • Hans B Rahr
  • Knud T Nielsen
  • Søren Laurberg
  • Nils Brünner
  • Hans Jørgen Nielsen
View graph of relations

The aim of the present study was to test the hypothesis that high serum YKL-40 associates with colorectal cancer in subjects at risk of colorectal cancer. We measured serum YKL-40 in a prospective study of 4,496 Danish subjects [2,064 men, 2,432 women, median age 61 years (range, 18-97)] referred to endoscopy due to symptoms or other risk factors for colorectal cancer. Blood samples were collected just before large bowel endoscopy. Serum YKL-40 was determined by ELISA. Serum YKL-40 was higher (P < 0.0001, unadjusted for confounding covariates) in subjects diagnosed with colon cancer (median 126 μg/L, 25%-75%: 80-206 μg/L) and rectal cancer (104, 72-204 μg/L) compared with subjects with adenoma (84, 53-154 μg/L), other nonmalignant findings (79, 49-138 μg/L), and no findings (62, 41-109 μg/L). Serum YKL-40 independently predicted colorectal cancer [OR, 1.53; 95% confidence interval (CI), 1.40-1.67; AUC = 0.68, P < 0.0001]. Restricting the analysis to subjects with no comorbidity increased the OR for serum YKL-40 to predict colorectal cancer (OR, 1.82; 1.58-2.08; AUC = 0.73, P < 0.0001). Combining serum YKL-40 and CEA demonstrated that both were significant [(YKL-40, OR, 1.27; 95% CI, 1.16-1.40); (CEA, OR, 1.92; 1.75-2.10; AUC = 0.75, P < 0.0001; OR for a 2-fold difference in marker level)]. Multivariable analysis (YKL-40, CEA, age, gender, body mass index, and center) showed that serum YKL-40 was a predictor for colorectal cancer in individuals without comorbidity (OR, 1.25; 95% CI, 1.05-1.40; P = 0.012), whereas this was not the case for those with comorbidity (OR, 0.98; 95% CI, 0.84-1.14; P = 0.80). In conclusion, high serum YKL-40 in subjects suspected of colorectal cancer and without comorbidity associates with colorectal cancer. Determination of serum YKL-40 may be useful in combination with other biomarkers in risk assessment for colorectal cancer. Cancer Epidemiol Biomarkers Prev; 24(3); 621-6. ©2015 AACR.

Original languageEnglish
JournalCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Volume24
Issue number3
Pages (from-to)621-6
Number of pages6
ISSN1055-9965
DOIs
Publication statusPublished - Mar 2015

ID: 45108119